Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating senile dementia

A technology for senile dementia and medicine, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of side effects, single effect of senile dementia, limited therapeutic effect, etc.

Inactive Publication Date: 2017-10-27
HEFEI CHUANDI MEDICAL TECH
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But above-mentioned drug treatment senile dementia effect is single, and therapeutic effect is limited, has certain side effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] A medicine for the treatment of Alzheimer's disease. The raw material formula is as follows:

[0022] 120 parts of kaempferol, 400 parts of Rhodiola, 160 parts of Acorus calamus, 120 parts of Syringa vulgaris, 80 parts of Rhodiola, 60 parts of Dilong Charcoal, 20 parts of Acetyl-L-Carnitine, 1200 parts of Red Hair, 14 parts of Motherwort

Embodiment 2

[0024] A medicine for the treatment of Alzheimer's disease. The raw material formula is as follows:

[0025] 180 parts of kaempferol, 250 parts of Rhodiola, 200 parts of Acorus calamus, 160 parts of Clove, 120 parts of Rhodiola, 30 parts of Dilong Charcoal, 8 parts of Acetyl-L-Carnitine, 800 parts of Red Hair, 10 parts of Motherwort.

Embodiment 3

[0027] A medicine for the treatment of Alzheimer's disease. The raw material formula is as follows:

[0028] 140 parts of Kaempferol, 300 parts of Rhodiola, 160 parts of Acorus calamus, 120 parts of Syringa vulgaris, 85 parts of Rhodiola, 30 parts of Dilong Charcoal, 10 parts of Acetyl-L-Carnitine, 850 parts of Red Hair, 10 parts of Motherwort.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating senile dementia. The medicine comprises the following components in parts by mass: 120-180 parts of kaempferol, 250-400 parts of rhodiola rosea, 160-200 parts of grassleaf sweelflag rhizome, 120-160 parts of ludwigia octovalvis, 80-120 parts of rhodiola rosea, 30-60 parts of lumbricus peptide, 8-20 parts of acetyl-L-carnitine, 800-1200 parts of radix gaulophylli and 10-14 parts of leonurus. An applicant obtains a scientific and reasonable medicine formula for treating the senile dementia by great experimental researches. The invention belongs to treatment of the senile dementia by using the kaempferol for the first time. After various medicines are combined, the efficacy of the medicines is matched, so that the medicine can treat the senile dementia caused by various reasons, and is good in effect and rapid in effect taking.

Description

Technical field [0001] The invention relates to a medicine for treating senile dementia. Background technique [0002] Alzheimer's disease (AD) is a commonly occurring neurodegenerative disease. As many as 50%-60% of dementia patients are AD, and the main clinical symptoms are progressive cognitive decline. A large number of studies have confirmed that there will be abnormal accumulation of β-amyloid (Aβ) in the brains of AD patients. Among them, Aβ25-35 has a direct toxic effect on nerve cells and is the main toxic fragment of β-amyloid. It is feasible to prepare an AD in vitro model. [0003] At present, the drugs approved at home and abroad for the treatment of Alzheimer's disease mainly include (1) Cholinesterase inhibitors, and the commonly used drugs include donepezil and galantamine. (2) Glutamate receptor antagonists, commonly used drugs are memantine hydrochloride. However, the above-mentioned drugs have a single effect in the treatment of senile dementia, with limited...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/888A61P25/28A61K31/221A61K31/352A61K35/62
CPCA61K31/352A61K31/221A61K35/62A61K36/185A61K36/29A61K36/41A61K36/533A61K36/888A61K2300/00
Inventor 秦杰军秦川
Owner HEFEI CHUANDI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com